MedWatch

Novo Nordisk's analog insulin will be sold cheaply in Walmart

Novo Nordisk will produce an insulin analog for the retail giant Walmart, which will be offering the drug at far lower prices than competing drugs for patients without insurance.

US retail giant Walmart will soon be selling its own brand of analog insulin, which will be produced by Novo Nordisk, according to Bloomberg News.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs